Clinical trial
A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And…
NCT00297206 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00297206 |
|---|---|
| Title | A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children |
| Official title | An Open-label, Single-dose, Multicenter, Pharmacokinetic, Safety and Tolerability Study of Valaciclovir Oral Suspension in Infants and Children. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Herpes Simplex |
| Intervention type | Drug |
| Interventions | Valaciclovir |
| Enrollment | 36 |
| Start date | Jan 25, 2003 |
| Primary completion | Feb 28, 2007 |
| Completion | Feb 28, 2007 |
| First posted | Feb 28, 2006 |
| Last update posted | Sep 11, 2017 |
| Countries | Chile, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: